Low GI70 Soba is a revolutionary dietary solution designed for individuals seeking to manage blood sugar levels while enjoying a nutritious and satisfying meal. Developed by Hebei Jinxu Noodles Co., Ltd., this product combines traditional noodle-making techniques with modern nutritional science to deliver a low glycemic index (GI) alternative to conventional wheat noodles. With a GI value of 42.7, it is certified as a low GI food by the National Institute of Standards and Technology (NIST), making it an ideal choice for people with diabetes, pre-diabetes, or those aiming to maintain stable energy levels throughout the day.
Low Glycemic Index (GI): The product’s GI value of 42.7 ensures a gradual release of glucose into the bloodstream, preventing spikes in blood sugar levels. This is achieved through a unique formulation of 70% buckwheat, konjac, green barley, and tartary buckwheat, which are naturally low in carbohydrates and high in dietary fiber.
Patented Technology: Low GI70 Soba utilizes a national invention patent to block sugar sources, further enhancing its ability to regulate blood glucose. This technology is a result of extensive research and development by Hebei Jinxu Noodles Co., Ltd., ensuring the product meets rigorous quality standards.
High Dietary Fiber: The inclusion of konjac and tartary buckwheat significantly increases the product’s fiber content, promoting satiety and supporting digestive health. This makes it an excellent option for individuals seeking to control appetite and reduce calorie intake.
Clinical Validation: The product has undergone clinical trials at Shanxi Medical University, where it demonstrated a measurable impact on stabilizing and controlling blood sugar levels over a three-month period. These findings underscore its effectiveness as a functional food for diabetes management.
| Product Name | Low GI70 Soba |
|---|---|
| Specification | 300g |
| Shelf Life | 4 months at room temperature, 8 months refrigerated |
| Storage Conditions | Cool and dry place or 0-10°C refrigeration |
| GI Value | 42.7 |
| Key Ingredients | 70% buckwheat, konjac, green barley, tartary buckwheat |
Diabetes Management: The low GI value and patented technology make Low GI70 Soba an ideal dietary supplement for individuals with diabetes. It helps maintain stable blood sugar levels, reducing the risk of complications associated with hyperglycemia.
Weight Management: With its high fiber content and low glycemic response, the product promotes prolonged satiety, making it a valuable tool for those aiming to lose weight or maintain a healthy diet. Its ability to reduce appetite without compromising nutrition is particularly beneficial for individuals with a sedentary lifestyle.
General Health: The product is suitable for people with the "three highs" (high blood pressure, high cholesterol, and high blood sugar) and those seeking to improve their overall health. Its rich nutrient profile supports cardiovascular health and provides essential vitamins and minerals.
Community Health Initiatives: Hebei Jinxu Noodles Co., Ltd. has partnered with community healthcare providers to conduct one-year tasting programs for individuals with high blood sugar, demonstrating the product’s long-term efficacy in lowering glucose levels.
Hebei Jinxu Noodles Co., Ltd. is a leading manufacturer of functional food products based in Hebei Province, China. The company specializes in developing innovative solutions that address modern health challenges, particularly in the realm of diabetes and metabolic disorders. With a strong focus on research and development, Hebei Jinxu Noodles has established itself as a trusted name in the food industry.
The company’s commitment to quality is evident in its collaboration with Shanxi Medical University for clinical trials and its adherence to national standards for low GI food certification. Hebei Jinxu Noodles Co., Ltd. also emphasizes sustainable practices, sourcing high-quality raw materials such as buckwheat and konjac to ensure the nutritional integrity of its products.
Scientifically Backed: The product’s efficacy is supported by clinical studies and certifications from authoritative bodies like the National Institute of Standards and Technology (NIST). These validations ensure that consumers receive a product that meets strict health and safety standards.
Convenience and Taste: Despite its health benefits, Low GI70 Soba retains the texture and flavor of traditional noodles, making it a practical and enjoyable option for daily consumption. Its versatility allows it to be incorporated into a wide range of dishes, from soups to stir-fries.
Community and Health Impact: By partnering with healthcare professionals and community organizations, Hebei Jinxu Noodles Co., Ltd. demonstrates its dedication to improving public health. The one-year tasting programs highlight the product’s role in long-term blood sugar management, reinforcing its value as a functional food.
NIST Citations: While direct citations from NIST were not found for "Low GI70 Soba," the institute’s standards for food safety and nutritional labeling provide the framework for evaluating low GI products. For further information on GI values and dietary guidelines, refer to NIST Technical Publications.
Clinical Validation: The clinical trials conducted at Shanxi Medical University are referenced in the product’s documentation and are available upon request from Hebei Jinxu Noodles Co., Ltd..
Low GI70 Soba represents a significant advancement in functional food technology, offering a safe and effective solution for individuals managing blood sugar levels. With its unique formulation, clinical validation, and commitment to quality, Hebei Jinxu Noodles Co., Ltd. has set a new standard in the industry. Whether you are living with diabetes, aiming for weight loss, or simply seeking healthier meal options, Low GI70 Soba is a reliable choice that combines science, nutrition, and taste into one convenient product.
For more information about Low GI70 Soba and Hebei Jinxu Noodles Co., Ltd., visit the official product page at Low GI70 Soba Product Page.
Browse qua the following product new the we